Investing in Assertio Holdings, Inc. (ASRT)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)7.62778
Intrinsic value (DCF)12.571348
Graham-Dodd Method11.921273
Graham Formula35.133947

Company description

Assertio Therapeutics Inc (ASRT) is an innovative pharmaceutical company that strives to improve the lives of patients by developing and commercializing high-quality treatments for various medical conditions. With a focus on pain management, neurology, and oncology, the company utilizes its expertise in clinical research and development to create novel therapeutics. Through a combination of its own research and strategic collaborations, Assertio is able to bring these life-changing medications to market. As a publicly-traded company, ASRT is committed to transparency and responsible corporate practices, continuously striving to create value for its shareholders, employees, and most importantly, patients. With a strong pipeline of promising drugs and a dedicated team of experienced professionals, Assertio Therapeutics is poised for continued success in the pharmaceutical industry.